Annual Financial Report & Notice of AGM

Summary by AI ^BETAClose X

Integrated Diagnostics Holdings plc has published its 2025 Annual Report and Accounts, following its full-year results announcement on April 17, 2026. The company has also distributed the 2025 Annual Report, the Notice of the 2026 Annual General Meeting, and a Letter of Availability to shareholders. The AGM is scheduled for May 19, 2026, and shareholders are encouraged to submit proxy votes online or via the Investor Centre app. The 2025 Annual Report and the Notice of the 2026 AGM have been submitted to the National Storage Mechanism.

Disclaimer*

Integrated Diagnostics Holdings PLC

23 April 2026

Integrated Diagnostics Holdings plc

(the "Company")

Annual Financial Report & Notice of Annual General Meeting

Following the announcement on 17 April 2026 of its full year results for the year ended 31 December 2025 (RNS number: 8399A), the Company announces that it has published the 2025 Annual Report and Accounts ("2025 Annual Report") on the Company's website:

https://investors.idhcorp.com/en/reports-and-presentations

The Company has also today posted the following documents to shareholders:

· 2025 Annual Report;

· Notice of 2026 Annual General Meeting (AGM); and

· Letter of Availability.

The Company's AGM is scheduled to be held at 3:00 p.m. BST on Tuesday, 19 May 2026 at Strand Hanson LTD, 26 Mount Row, Mayfair, London W1K 3SQ.

If you are unable to attend the AGM but would like to vote on the resolutions, the Company kindly requests shareholders to submit a proxy vote online at https://uk.investorcentre.mpms.mufg.com/ or via the Investor Centre app, via CREST or if you are an institutional investor via Proxymity in accordance with the instructions set out in note 2 of the Explanatory Notes to the Notice of AGM which can be found on the Company's website https://www.idhcorp.com/. Shareholders wishing to access the dial-in facility or submit questions are asked to email tarek.yehia@idhcorp.com by close of business on Wednesday, 13 May 2026.

In accordance with UK Listing Rules 22.2.6 and 22.2.7 and the UK Disclosure Guidance and Transparency Rules ("DTRs") 6.2.10R and 6.3.5R, the 2025 Annual Report has been submitted to the National Storage Mechanism ("NSM") in both structured electronic format and in unedited full text and the Notice of the 2026 AGM has been submitted to the NSM. A copy of the 2025 Annual Report and Notice of the 2026 AGM is available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information please contact:

Integrated Diagnostics Holdings plc
Tarek Yehia Investor Relations Director	+20(0)1068826678

Company Secretary MUFG Corporate Governance Limited	IDHLondon@mpms.mufg.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END